Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251248 | SCV000303620 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000459428 | SCV000557304 | benign | Primary ciliary dyskinesia | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001618379 | SCV001845645 | benign | not provided | 2019-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000459428 | SCV002651664 | benign | Primary ciliary dyskinesia | 2015-12-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002503925 | SCV002805282 | benign | X-linked cone-rod dystrophy 1; Retinitis pigmentosa 3; Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness; Macular degeneration, X-linked atrophic | 2022-04-08 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001618379 | SCV005276112 | benign | not provided | criteria provided, single submitter | not provided |